Flavin Financial Services’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.02M Sell
20,778
-2,518
-11% -$348K 1.63% 21
2026
Q2
$2.99M Buy
23,296
+3,163
+16% +$370K 1.71% 23
2026
Q1
$2.42M Buy
20,133
+301
+2% +$34.8K 1.63% 23
2025
Q4
$2.09M Sell
19,832
-1,220
-6% -$115K 1.43% 27
2025
Q3
$1.77M Buy
21,052
+4,481
+27% +$369K 1.26% 30
2025
Q2
$1.31M Sell
16,571
-975
-6% -$77.5K 1.27% 30
2025
Q1
$1.57M Buy
17,546
+860
+5% +$80.3K 1.45% 29
2024
Q4
$1.66M Buy
+16,686
New +$1.72M 1.58% 26

Other funds holding MRK

Flavin Financial Services's MRK Position: Q3 2026 in Review

Flavin Financial Services reduced its Merck (MRK) stake by 11% in Q3 2026, selling an estimated $348K and leaving 20,778 shares worth $3.02M. The position accounts for 1.63% of the portfolio, ranked #21.

Flavin Financial Services first reported a position in MRK in Q4 2024 and has held it in 8 quarters since. 1,788 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Flavin Financial Services held 20,778 shares of Merck worth $3.02M as of Q3 2026.
  • Flavin Financial Services sold 2,518 Merck shares in Q3 2026, an estimated $348K.
  • Merck made up 1.63% of Flavin Financial Services's portfolio in Q3 2026, its #21 holding.
  • Flavin Financial Services first reported a position in Merck in Q4 2024 and has held it in 8 quarters since.
  • 1,788 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Flavin Financial Services's 13F filing for Q3 2026, filed 21 Oct 2026.